The annual Alzheimer's Disease & Related Dementias Research Day is designed to encourage collaboration and promote scientific thought among faculty, students and researchers from a wide range of disciplines across the UW–Madison campus.
The annual 'Science Expeditions' at UW–Madison is a FREE, family-friendly series of events, open to the public, to showcase the research and innovation happening on the UW campus.
The LGBTQ+ Health Summit educates and activates the health sciences community on LGBTQ+ health and creates new pathways to serve LGBTQ+ communities.
Join a discussion on disability rights with Judith Heumann, a lifelong advocate for disability rights, and author and UW–Madison alum, Kristen Joiner.
Dr. Lyle Ignace will discuss the overall health disparities that exist in the Wisconsin Native American community, and the challenges that an ongoing pandemic has magnified.
Please join us for this virtual session to celebrate UW's clinical trials achievements, learn more about our clinical research goals, and the value of clinical trials from those directly involved, including researcher and participant perspectives.
In this Introduction to ClinicalTrials.gov, we will review a brief history of CT.gov including its original intent and the relevant laws, policies, guidance, best practices, and advocacy groups that have shaped CT.gov into its present form.
This session will explore the ways in which QUALITY is different from COMPLIANCE.
Grab your running shoes, walking sticks, set of wheels, or whatever you’d like – Roll & Stroll is back in person for 2022! All you have to do is choose your registration type, create your fundraising goal, and join us in our fundraising endeavor.
Join this session to gain an understanding of how FDA drug and device requirements apply to research activities.
Explore the pain points of decentralized clinical trials, including costs, budgeting, training, support, staffing, resources, and more.
This webinar will discuss the costs and consequences of failing to address the lack of representation in clinical trials; barriers to addressing underrepresentation; and examples of successful efforts to improve inclusion across diverse populations in clinical trials for diseases associated with high mortality rates in the United States.
